l-carnitine tmao koeth 2013 nature medicine γ–Butyrobetaine is a pro-atherogenic intermediate in gut microbial metabolism of to Frontiers | TMAO as a
Frontiers TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review Meat metabolizing bacteria in atherosclerosis Nature Medicine L Carnitine intake and high trimethylamine N oxide plasma levels correlate with low aortic lesions in ApoE transgenic mice expressing CETP ScienceDirect Gut Metabolite Trimethylamine N Oxide in Atherosclerosis: From Mechanism to Therapy Frontiers Effects of choline metabolitetrimethylamine N oxide on immunometabolism in inflammatory bowel disease Frontiers
Pay in 4 interest-free payments of $6.02 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17




